A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen®) 200 mg/5 ml Oral Suspension

计划入组 74 人 · 首次发布于 2025 年 6 月 25 日

Bioequivalence study of Empagliflozin Metformin 12.5-1000 mg

计划入组 24 人

Bioequivalence study of Metformin 500 mg tablet

计划入组 24 人

EGFR inhibitors (Vichem Chemie)

CDK9 inhibitors (Vichem Chemie/Rega Institute/ViroStatics)

gap junction blockers (Vichem)

Wacker Chemie Ag

Norway

BERLIN-CHEMIE AG

Bulgaria

G.C. Chemie Pharmie Ltd.

India

Wacker Opens New Biotechnology Center in Munich to Accelerate Biopharmaceutical Research

Wacker Biotech and Expression Manufacturing Form Strategic Partnership to Accelerate Lentiviral Gene Therapy Development

MinervaX and Wacker Biotech Collaborate to Advance Group B Streptococcus Vaccine Production